Cargando…
Therapy-related Acute Lymphoblastic Leukaemia has a Unique Genetic Profile Compared to De Novo Acute Lymphoblastic Leukaemia
Background: Unlike therapy-related myeloid neoplasms, therapy-related acute lymphoblastic leukaemia (tr-ALL) is poorly defined due to its rarity. However, increasing reports have demonstrated that tr-ALL is a distinct entity with adverse genetic features and clinical outcomes. Methods: We compared t...
Autores principales: | Kook, Hye Won, Kim, Jin Ju, Park, Mi Ri, Jang, Ji Eun, Min, Yoo Hong, Lee, Seung-Tae, Shin, Saeam, Cheong, June-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516015/ https://www.ncbi.nlm.nih.gov/pubmed/36186901 http://dx.doi.org/10.7150/jca.76719 |
Ejemplares similares
-
Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019) -
Targeted Therapy in Acute Lymphoblastic Leukaemia
por: Salvaris, Ross, et al.
Publicado: (2021) -
Effect of Aplidin in acute lymphoblastic leukaemia cells
por: Erba, E, et al.
Publicado: (2003) -
Cytotoxicity of tamoxifen for acute lymphoblastic leukaemia in vitro.
por: Blatt, J., et al.
Publicado: (1984) -
Seasonality in the diagnosis of childhood acute lymphoblastic leukaemia.
por: Thorne, R., et al.
Publicado: (1998)